Copyright © 2019. Inderes Oy. All rights reserved.
Search
User account

Hei!

Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.

Oliko sinulla jo tili?

Log in
DNA
3263 investors follow this company
The company is not covered. See all listed companies from here.
BUY 20.88 LOWEST 20.78 VOLUME 1 797
SELL 20.90 HIGHEST 20.90 VALUE 0,037 Milj. EUR

Would you like to see our recommendations and target prices?

You already have an Inderes account? Log in from here.

Latest insider trading

Type: stock_exchange_release
8.11.
2019

DNA PLC STOCK EXCHANGE RELEASE 8 November 2019 at 8:30 am EET

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Type: stock_exchange_release
1.11.
2019

DNA PLC STOCK EXCHANGE RELEASE 1 NOVEMBER 2019, 8:05 am (EEST)

DNA's CEO Jukka Leinonen has been appointed head of Telenor Group’s Nordic cluster and a member of Telenor’s Group Executive Management. He will continue in his role as CEO of DNA in addition to his new responsibilities.

Part of his new role is to act as the chair of Telenor Sweden and Telenor Denmark. He will report directly to Sigve Brekke, the President & CEO of Telenor Group.

Type: stock_exchange_release
31.10.
2019

DNA PLC STOCK EXCHANGE RELEASE 31 OCTOBER 2019, 11:15 pm (EEST)

DNA Plc's Extraordinary General Meeting was held in Helsinki on 31 October 2019.

Type: stock_exchange_release
22.10.
2019

DNA PLC STOCK EXCHANGE RELEASE 22 OCTOBER 2019, 8:30 AM EEST

DNA arranges two news conferences today. News conference for media and analysts in Finnish is held at 10:00 am Finnish time. Conference call for analysts and institutional investors in English is at 1:00 pm Finnish time. Details of the events can be found at the end of this release.

Type: stock_exchange_release
16.10.
2019

DNA PLC MANAGERS' TRANSACTIONS 16 October, 2019 at 10:30 am EET

DNA has received a notification from Pekka Väisänen, DNA's Senior Vice President, Consumer Business, of a transaction made with DNA's financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given here under.

____________________________________________

Type: stock_exchange_release
15.10.
2019

DNA PLC STOCK EXCHANGE RELEASE 15 OCTOBER 2019, 10:45 am EEST

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Type: stock_exchange_release
15.10.
2019

DNA Plc, Stock Exchange Release, 15 October 2019 at 9:00 am EEST

DNA’s operations have developed favourably in 2019, even though competition has remained intense. Net sales have been positively affected by strong mobile service revenue and brisk mobile equipment sales. Better-than-expected net growth in postpaid subscription sales, particularly during the third quarter, have a positive impact on the full-year outlook.

In line with our estimate for the end of the year, we raise DNA’s guidance for 2019 as regards net sales.

Type: stock_exchange_release
11.10.
2019

DNA PLC STOCK EXCHANGE RELEASE 11 OCTOBER 2019, 10:30 am EEST

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Type: stock_exchange_release
4.10.
2019

DNA PLC STOCK EXCHANGE RELEASE 4 OCTOBER 2019, 9:00 am EEST 

Type: stock_exchange_release
3.10.
2019

DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EEST

DNA has received a notification from Jukka Ottela, Member of the Board, of a transaction made with DNA’s financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given here under.
____________________________________________

Person subject to the notification requirement
Name:                                  Jukka Ottela
Position:                               Member of the Board

DNA

English translation unavailable for DNA.
DNA